跳至主要内容
临床试验/jRCT1022250054
jRCT1022250054招募中不适用

Evaluation of the Diagnostic Accuracy for Early Malignant Transformation of Oral Mucosal Diseases Using IPCL Classification via Narrow Band Imaging and Brush Cytology and Needle Cytology

未提供0 个研究点目标入组 130 人开始时间: 待定

试验速览

阶段
不适用
状态
招募中
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study

入排标准

年龄范围
20age old over 至 No limit(—)
性别
All

入选标准

  • Patients undergoing follow-up for oral cancer who are attending the Oral Surgery Department of the Dental Care Centre at the Uchimaru Medical Centre from 1 December 2023 to 31 March 2026, or the Oral Surgery Department of Iwate Medical University Hospital from 1 April 2026 to 1 December 2026, and who have oral mucosal lesions suspected of malignancy, orally latent malignant lesions, and oral cancer, and who consent to participation in this study.

排除标准

  • (1) When the patient has severe physical symptoms making cooperation with the study difficult
  • (2) When the patient has severe mental symptoms (severe cognitive impairment, severe depressive state) making cooperation with the study difficult
  • (3) When the patient has difficulty understanding Japanese
  • (4) Other cases where the investigator deems participation in the study inappropriate
  • (5) When the patient is a minor

研究者

发起方
未提供

相似试验

招募中
不适用
Research on Early Screening and Diagnosis of Pulmonary Nodules Based on Novel Non-invasive Technologies.Lung Cancer
NCT07370077Chen KeZhong1,800
进行中(未招募)
1 期
A clinical study in men with prostate cancer undergoing surgery to assess the accuracy of 99mTc-MIP-1404 imaging as compared to pathology resultsProstate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864
EUCTR2012-001864-30-BEMolecular Insight Pharmaceuticals, Inc100
进行中(未招募)
不适用
Phase 2 study to assess the effectiviness of the investigational drug 99mTc-MIP-1404 in detecting prostate cancer tissue within the prostate gland and elsewhere in human body.Prostate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 15.0Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-001864-30-HUMolecular Insight Pharmaceuticals, Inc100
进行中(未招募)
1 期
Phase 2 study to assess the effectiviness of the investigational drug 99mTc-MIP-1404 in detecting prostate cancer tissue within the prostate gland and elsewhere in human body.Prostate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864
EUCTR2012-001864-30-CZMolecular Insight Pharmaceuticals, Inc100
进行中(未招募)
不适用
A clinical study in men with prostate cancer undergoing surgery to assess the accuracy of 99mTc-MIP-1404 imaging as compared to pathology resultsProstate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864
EUCTR2012-001864-30-NLMolecular Insight Pharmaceuticals, Inc100